2

3
 WELCOMING SPEECH
Ladies and gentlemen, distinguished colleagues, and esteemed participants.

Welcome to the apex of scientific exploration in the field of cardio-

thoracic surgery – the Malaysian Association for Thoracic and Cardio-vascular
Surgery. Our theme for this year, “Interdisciplinary in Cardiothoracic Surgery”,
is not merely a phrase but a clarion call to the forefront of medical innovation. In an
epoch where the complexities of cardiovascular and thoracic pathologies defy
conventional silos of specialization, we find ourselves poised at the crossroads of
transformative collaboration. The theme demands that we traverse the frontiers of
medical science by synergizing the collective wisdom and skillsets of cardiac
surgeons, thoracic surgeons, cardiologists, anesthesiologists, pulmonologist,
radiologists, and allied health professionals.

Within the crucible of our pre-congress workshops, we shall cultivate expertise and engender
innovation. The "Live Animal VATS Workshop" stands as a testament to our commitment to cutting-edge
minimally invasive techniques, where intricate procedures are dissected and refined. The "Allied Health Pro-
fessional Enclave" and "Perfusionist Enclave" underscore the indispensable roles played by these essential
members of our surgical teams, where teamwork is imperative. The "Postgraduate Lectures" form the corner-
stone of intellectual fortitude, beckoning us to traverse the profound depths of our field, in our commitment to
train our future surgeons.

My profound gratitude goes to the international and local speakers. Thank you for your time to
share your knowledge, experience and expertise. My thanks also go to the rest of the organizing committee,
members of the Pusat Jantung dan Paru-Paru Hospital Canselor Tuanku Muhriz, who have helped me metic-
ulously architected this intellectual symphony.

In no lesser measure, we acknowledge our sponsors whose steadfast support fuels the engines
of scientific progress. Their financial commitment ensures that our expedition into knowledge and innovation
remains undaunted by fiscal constraints, enabling us to forge new horizons in cardiothoracic surgery.

In conclusion, I extend my profound gratitude to all of you for your presence and unwavering
dedication to the advancement of cardiothoracic surgery. I hope you enjoy and embrace the maximum form
the congress. Together, we stand on the precipice of unprecedented heights, poised to inscribe indelible
marks upon the annals of medical history.

Thank you.

DR MUHAMMAD ISHAMUDDIN ISMAIL

Organising Chairman

4
 PRESIDENTIAL ADDRESS
Assalamualaikum and greetings from Kuala Lumpur.

Bismillahirrahmanirrahim and Salutations to His Holy Prophet Peace be Upon Him.

It is my great pleasure to welcome all of you to the 23rd Annual

Scientific Meeting 2023 of the Malaysian Association for Thoracic and Cardio-
vascular Surgery (MATCVS) in Putrajaya Malaysia 14th to 16th September 2023.
To date, the MATCVS remains the sole organisation representing the fraternity in
Malaysia and has become a key opinion leader in policy discussions education and
training in relation to cardiothoracic surgery.
This is a much awaited event aimed at providing opportunities for
everyone involved in the practice of cardiothoracic and vascular surgery in Malaysia to get together, share
knowledge, experiences and participate in continuous medical education. Interdisciplinary Cardiovascular
and Thoracic Surgery have been chosen as the theme for this year’s meeting to commemorate the
fundamental aspect of our specialty which has been taken for granted for far too long. Indeed, cardiothoracic
surgery remains the most beautiful showcase of cooperation among specialists of various related disciplines
including heterogenous groups of trained personnel and paramedic officers.
The organising committee which mainly comprised of esteemed members of the MATCVS in
Pusat Jantung dan Paru-Paru Hospital Canselor Tuanku Muhriz (HCTM) have assembled a great program
including pre-congress events touching various branches of cardiothoracic surgery, with input by key lecturers
and speakers who are local and regional giants in their respective fields of interest. We are extremely
grateful, privileged and excited to have His Royal Highness Yang Dipertuan Besar Negeri Sembilan Tuanku
Muhriz Ibni Almarhum Tuanku Munawir’s presence in order to grace the opening event. We are also very
honoured to have Professor Dr Alistair Royse from Melbourne Australia to deliver the Razali Hashim Memori-
al Lecture where we hope he will share with us his vision on the future direction coronary artery surgery.
I would like to express my deepest appreciation and gratitude to my colleagues in HCTM and the
MATCVS council who have taken great time and effort in putting this rich programme together with the aim of
making this meeting a success and a memorable one. I would also like to thank all members of the faculty,
keynote speakers, facilitators, junior doctors and trainee surgeons, paramedic officers who have submitted
free papers making the conference a focal hub for latest updates in the field. We are also appreciative of all
members of the industry and sponsors who have contributed so much and lastly Ministry of Health Malaysia
who have always supported the MATCVS in all training and education activites in recent years .
Once again, welcome to MATCVS 2023 Putrajaya and please enjoy the vibrance of this great
new city, uniqueness and local culinary delicacies. I sincerely hope you will have a pleasant stay and wishing
you a successful meeting .

Thank you

DATO’ DR BASHEER AHAMED ABDUL KAREEM

President
Malaysian Association for Thoracic and Cardiovascular Surgery

5
EXECUTIVE COUNCIL 2021-2023

President
Dato’ Dr Basheer Ahamed Abdul Kareem

Immediate Past President

Tan Sri Dato’ Dr Yahya Awang

Vice President
Dato’ Sri Dr Jeswant Dillion

Hons Secretary
Prof Dr Chan Kok Meng, John

Hons Treasurer
Mr Sivakumar A/L Sivalingam

Committee Members
Dato’ Dr Mohd Hamzah Kamarulzaman
Dato’ Dr Mohamed Arif Bin Mohammad Nor
Dato’ Dr Abu Yamin Bin Khamis
Dr Alwi Bin Mohamed Yunus

6
 ORGANISING COMMITTEE
Advisors Pre-Congress Sub Committee
Dato’ Dr Basheer Ahamed Abdul Kareem Prof Dr Shahrul Amry
ACP (K) Prof Dato’ Sri Dr Mohd Ramzisham Dr Katijjahbe Md Ali
Nurdiyana Ismail
Co Advisor Amar ‘Aizat Bin Abdul Razak
Dato’ Dr Mohd Hamzah Kamarulzaman Mohd Hisyam Bin Mohd Puad
Dr Syed Adeeb Puan Maziah Binti Man
Tan Sri Dr Syed Jalaluddin Puan Sakinah Binti Awang @ Harun
KJ Marini Abdul Hadi
Chairman Puan Noorazlina Abdul Rani
Dr Muhammad Ishamuddin Ismail KJ Nik Elina Ahmad

Secretary Annual General Meeting and

Prof Madya Dato’ Dr Nur Ayub Md Ali Election Committee
Prof Madya Dato’ Dr Nur Ayub Md Ali
Deputy Secretary Dr Adli Azam Bin Mohammad Razi
Dr Nursuhada Mohamed Yusof Dr Lam Hong Yoong
Dr Katijjahbe Md Ali Dato’ Dr Hairulfaizi Haron
Mdm. Irene Lourdes Dr Ahmad Zuhdi Mamat
Dr Saravana Kumar Karupiah
Treasurer
Dato’ Dr Hairulfaizi Haron Conference Committee
Dr Sivakumar a/l Sivalingam Dr Siti Laura Mazalan
Dato’ Dr Faisal Ismail Dr Abdul Raqib Bin Abd Ghani
Dr Abdul Rashid bin Mohd Radzif
Scientific Committee Dr Ahmad Khalis bin Nazib
Prof Madya Dr Sivakumar Krishnasami Dr Ahmad Mahir bin Shamsuddin
Prof Dr John Chan Kok Meng Dr Chang Tze Sen
Prof Dato' Sri Dr Jeffrey Jeswant Dillon Dr Chen Yen Chuan
Dato' Dr Mohd Fikri Abdullah Dr Cheng Kok Mun
Prof Madya Dato’ Dr Nur Ayub Md. Ali Dr Er Chee Yik
Dr Ho Yan Le

7
 ORGANISING COMMITTEE
Dr Kan Chan Siang
Dr Law Poh Suan
Dr Muhammad Ibrahim bin Azmi
Dr Nantha Kumar a/l Nadarajah
Dr Ng Juin Yi
Dr. Pau Cheong Ping
Dr See Woan Shiang
Dr Tan Yong Sheng
Dr Wong Kian Boon
Logistic Committee
En Muhammad Fairuz Muzakkir Mohd Shubri
En Asmawi Ananan Enmeran
Pn Norhidayah Idris
En Mohammad Amirul Abu Hassan
Pn Sarina Sulong @ Bidin
En Faizal Fauzam
Dr Khairul Anwar Bin Abdul Rahman
Dr Kanmani A/P Murugesu
Dr An Najjah Binti Tanmami
Dr Nur syamin binti ismail
Dr Khairul Farhan bin Khairuddin
Dr Farah Najla binti Supandi
Dr Tharanrajh a/l Arumugam
Dr Richelle, Chua Huey Bing
Dr Sarah Liyana Binti Mohd Hisham
Pn Zulina Mustafa
Pn Noraniza Mohamad Aziz
Pn Zuraihani Kamaludin
Pn Hasmizahshawalna Azmi
Pn Siti Nor Shafikah Zakaria
Mdm Irene Lourdes
Pn Siti Nor Baiti Mohd Rafae
Pn Nor Azlihan Mohd Ali
Special Task Committee
Pn J Sanarina Abdul Jabbar
Pn Dalilah Yusof
Pn Noorazlina Abdul Rani
Pn Nik Elina Ahmad
Multimedia Media and Design Committee
Ms Cassandra Francis
Dr Ng Juin Yi
Pn Amalina
Veterinary
Assoc Prof Dr Rumaizi Shaari
Dr Mimi Armiladiana Mohamad
Dr Nur Atikah Hashim
Dr Nadiah Syuhada Roslan
En Mohd Fakhrul Nizam Ab Rahman
En Mohd Nazri Mohamed Nor

Technical Committee
Pn Nur Anis A’dila Nor A’dlisham
Pn Paizah Paijan
Pn Hasliszaini Hussien
Pn Marini Abdul Hadi

8
 FACULTY SPEAKERS
INTERNATIONAL SPEAKERS

Prof Dr Alistair Royse Dr Aneez D B Ahmed

Australia Singapore

Assist. Prof. Dr Boonlawat Homvises Dr. Edmund Villaroman

Thailand Philippines

Dr. Harish Mithiran Assoc. Prof. Dr. Nelson Alphonso

Singapore Australia

Dr. Padungkiat Tangpiroontham

Thailand

9
 FACULTY SPEAKERS
MALAYSIAN SPEAKERS

Assoc. Prof. Dr. Sivakumar Dr. Adli Azam Mohammad Razi Dato' Dr Mohamed Hassan Ariff
Krishnasamy

Dr. Soon Sing Yang Dr. Adrian Ooi Seng Wae Dato' Dr. Mohd Fikri Abdullah

Prof. Dr. Mohd Zamrin Dimon Prof Dr John Chan Kok Meng Dr. Anand Sachithanandan

Dato’ Dr. Faisal Ismail Dr. Gerard Francis Lopez Dr. Nik Azuan Nik Ismail

10
 FACULTY SPEAKERS
MALAYSIAN SPEAKERS

Dr. Taufiq Abdullah Prof. Dr Arman Zaharil Mat Saad Dr. Siti Laura Binti Mazalan

Dr. Jong Yuan Hsun Prof Dato' Dr. Mohamed Ezani Md Dr. Dayang Zuraini Sahadan
Taib

Prof. Dato' Seri Dr. Jeffrey Jeswant Datuk Dr. Shaiful Azmi Yahaya Dr Hamat Hamdi Che Hassan
Dillon

Prof. Dr. Shahrul Amry Bin Hashim Dr. Paneer Selvam A/L Krishna Dr. Isa Azzaki Zainal
Moorthy

11
 FACULTY SPEAKERS
MALAYSIAN SPEAKERS

Dato’ Dr Oteh Maskon Assoc. Prof. Dr. Mohamed Faisal Dr. Kanesh Kumar A/L Doraisamy
Abdul Hamid

Assoc. Prof. Dr Andrea Ban Yu-Lin Dr. Nik Nuratiqah Nik Abeed Dr. Katijjahbe Md Ali
Taib

Dr. Mona Zaria Binti Nasaruddin Dr. Marfu'ah Nik Ezzamudden Assoc. Prof. Dr. Suriati Mohamed
Saini

Dr. Ng Khai Lip Dr. Thurston Erng Dr Kamilah Muhammad Hafidz

12
 FACULTY SPEAKERS
MALAYSIAN SPEAKERS

Dr. Sakinah binti Awang @ Harun Mr. Mok Chek Min

Mdm. Maziah binti Man Mr. Sam Ho

Mdm. Nurshariza A. Aziz

Mdm. Shazila binti Rosli

13
 RAZALLI HASHIM IN MEMORY
Dr Razalli Hashim was born on the 29th January 1947 in the
state of Perak Malaysia. He obtained his medical degree from
the University of Agra, India in 1965. He was conferred the
Fellowship of the Royal Australasian College of Surgeons in
1979.

He did his advanced training in cardiac surgery under the

legendary Sir Brian Gerald Barratt - Boyes at the Greenlane
Hospital, Auckland New Zealand and the Royal Children’s
Hospital Melbourne, Australia. After returning to Malaysia he was instrumental in setting
up the Cardiothoracic unit at the University Hospital in Petaling Jaya of which he became
the Head in 1985. He developed a passion for pediatric cardiac surgery and did further
training at the Mayo Clinic in Rochester, Minnesota USA. He was particularly known for
his excellent results in the surgical treatment of Tetralogy of Fallot.

Dr Razalli Hashim was a feisty gentleman, not afraid of confrontation and controversy.
“Why send our patients overseas when we can perform the operations here?” was his oft
repeated statement. As a tribute to his character Pn Hasnah bt Johar, who had worked
closely with him for a long time, said “he didn’t care whether the patients were rich or
poor. He treated them all the same”.

Unfortunately at the age of 40, Dr Razalli Hashim was diagnosed as having lung cancer.
This mender of hearts lost his battle with the disease on Valentine’s Day 14th February
1987. He is survived by his wife, Puan Juriah and four children.

The Malaysian Association of Thoracic and Cardiovascular Surgery decided to honour

him by dedicating a lecture named “The Razalli Hashim Memorial Lecture” delivered
during the Annual Scientific Meeting of the Association. Surgeons of the highest calibre
that have made inspiring contributions in the field of cardiothoracic surgery will be invited
to deliver the lecture.

14
THE RAZALLI HASHIM MEMORIAL LECTURE
PROF DR ALISTAIR ROYSE
Visiting Professor, Department of Surgery
Heart and Lungs Centre, Faculty of Medicine, Universiti Kebangsaan Malaysia

“Changing the coronary surgery landscape -Total arterial revascularization “

Prof Alistair Royse has been appointed as a Visiting Professor at the Surgery Department
Faculty of Medicine UKM. He is a Cardiothoracic Surgeon from the Royal Melbourne Hospital
and the University of Melbourne in Australia. He is also the director of e-learning technologies
for the Melbourne Medical School, and the co-director of the Ultrasound education group and
Mobile Learning Unit.

He has pioneered the use of arterial coronary bypass grafts and complex arterial
reconstructions. This has substantially changed the practice of coronary surgery in Australia
whereby the rate of total arterial revascularisation in Australia is approximately 10 times higher
than North America or Europe. He has also been intimately involved in the development of
clinical ultrasound including intraoperative ultrasound. He is a co-director of the ultrasound
education group, oversee a large distance education (eLearning) program with almost 40,000
students in 3 years. He was promoted via the academic stream to Professor in 2011 with more
than 240 peer reviewed papers. He has worked very closely with his brother, a cardiac
anaesthetist and other collaborators, Doa El-Ansari and her team in physiotherapy and they
published a randomised trial in the use of sternal plating.

At present, his key areas of clinical and research interest are related to total arterial
coronary revascularization where he has published widely and has just commenced the first
major randomized controlled trial on this topic with a $5 million grant in Australia.
15
 PROGRAM OVERVIEW
Day 1 – 14th September 2023 (Thursday)
Venue: ASSC, HCTM and Putrajaya Marriott Hotel

0730 – 0800 Registration

Perfusionist Enclave:
Live Animal VATS IABP Interactive Allied Health Postgraduate
Workshop* Workshop* Symposium* Symposium*

0800 – 1300 Venue: Venue: Venue: Venue:

ASSC HCTM Hall 2, Putrajaya Mar- Garden 3B, Putrajaya Garden 3A, Putrajaya
riott Hotel Marriott Hotel Marriott Hotel

*Please refer to the respective workshop’s itinerary for further details

Lunch symposium
1300 – 1400 Medtronic
Hall 2, Putrajaya Marriott Hotel

Session 1
1400 – 1530 Interdisciplinary in cardiothoracic surgery
Hall 2, Putrajaya Marriott Hotel

Tea break
1530 – 1545
Foyer Hall 2, Putrajaya Marriott Hotel
Continue Session 1
1545 – 1645 Interdisciplinary in cardiothoracic surgery
Hall 2, Putrajaya Marriott Hotel
END OF DAY 1

FACULTY DINNER
1900-2200 (By invitation only)
Putrajaya Marriott Hotel

16
 PROGRAM OVERVIEW
Day 2 – 15th September 2023 (Friday)
Venue: Hall 2, Putrajaya Marriott Hotel

0730 – 0800 Registration

0800 – 0930 Young Investigator Award Competition

Morning Break
0930 – 0945
(Preparation for opening ceremony)

0945 – 1030 Opening Ceremony

Session 2
1030 – 1230
Thoracic

1230 – 1300 Razali Hashim Memorial Lecture

Lunch Symposium/Friday Prayer

1300 – 1400
AstraZeneca

Continue Session 2
1400 – 1530
Thoracic

Tea Break
1530 – 1600
AstraZeneca

Continue Session 2
1600 – 1730
Thoracic

END OF DAY 2

17
 PROGRAM OVERVIEW
Day 3 – 16th September 2023 (Saturday)
Venue: Hall 2, Putrajaya Marriott Hotel

0730 – 0800 Registration

0800 – 0930 Oral presentation and poster presentation competitions

Morning break/Morning Symposium

0930 – 1000
Medtronic

Session 3
1000 – 1100
Coronary Surgery

Session 4
1100 – 1230
Valve Surgery

Lunch Symposium
1230 – 1330
Edwards Life Sciences

Session 5
1330 – 1530
Aortic Surgery

Session 6
1530 – 1620
Congenital Cardiac Surgery

1620 – 1640 Closing Ceremony, Prize Giving Ceremony & Lucky Draw

1640 – 1700 Tea Break

END OF DAY 3

MATCVS BIENNIAL GENERAL MEETING & ELECTION

1700 – 1830
Kuala Lumpur Room (Level 1), Putrajaya Marriott Hotel

18
 DAILY PROGRAM
DAY 1 (14TH SEPTEMBER 2023, THURSDAY)
Pre-congress Workshop

Workshop 1: Thoracic surgery

Theme : VATS animal workshop
Venue : Advanced Surgical Skill Center HCTM
Moderators : Assoc. Prof. Dr. Sivakumar Krishnasamy
Dr. Adli Azam Mohammad Razi

Program :
0730 – 0800 Registration

0800 – 0805 Opening speech

Dr. Muhammad Ishamuddin Ismail

0810 – 0825 Approaches in VATS

Assoc Prof Dr Sivakumar Krishnasamy

0830 – 0845 Lobectomy

Dr Adli Azam Mohammad Razi

0850 – 0905 Current approach to segmentectomy

Dr Edmund Villaroman

0910 – 0925 Lymph nodes dissection

Dr Soon Sing Yang

0930 – 0945 Managing complications in VATS

Dr Adrian Ooi Seng Wae

0945 – 1000 Tea break

1015 – 1300 Live animal workshop

Lobectomy
Segmentectomy
Lymph node dissection

1300 – 1400 Lunch break & move to Putrajaya Marriott Hotel for congress

19
 DAILY PROGRAM
DAY 1 (14TH SEPTEMBER 2023, THURSDAY)
Pre-congress Workshop

Workshop 2: Cardiac Perfusionist Enclave

Title : Fearless in Handling Intra-Aortic Balloon Pump (IABP) Therapy. An Interactive
Workshop
Venue : Hall 2, Putrajaya Marriott Hotel
Speakers : Mr Mok Chek Min, CCP
Mr Sam Ho, APAC Interventional Applications & Training

Program :
07:30 – 08:00 Registration

08:00 – 08:05 Welcome by Sponsor

08:05 – 08:30 Intra-Aortic Balloon Therapy – The Malaysian Clinical Study

08:30 – 09:00 Trigger and Timing

09:00 – 09:15 Balloon Pressure Waveform (BPW)

09:15 – 09:45 Clinical Application of BPW

09:45 – 10:00 Break

10:00 – 10:15 Indications and Contraindications

10:15 – 10:30 Complications

10:30 – 10:45 Weaning and Balloon Removal

10:45 – 11:00 Nursing Care & Patient Transfer Consideration

11:00 – 12:30 Interactive station – Participants are split into 3 stations (30 mins rotation):
Station 1: Balloon preparation, sizing & insertion with Arrow IAB
Station 2: Setup, startup, alarm & troubleshooting with Arrow AC3
Station 3: Heart model and timing with Arrow AC2

12:30 – 13:00 SimulationOnline interactive software, Q&A and wrap up

20
 DAILY PROGRAM
DAY 1 (14TH SEPTEMBER 2023, THURSDAY)
Pre-congress Workshop

Workshop 3: Allied Health Program

Theme : Towards better patient care in cardiac and thoracic surgery
Time : 0800 - 1230
Venue : Garden 3B, Putrajaya Marriott Hotel
Moderator : Dr Katijjahbe binti Md Ali
Dr Sakinah binti Awang @ Harun

Program :
0800 – 0830 Pain management in cardiothoracic surgery
Dr Kanesh Kumar A/L Doraisamy

0830 – 0900 Chest tube nursing diagnosis and care plan

Mdm Maziah binti Man

0900 – 0930 Nutritional support in cardiothoracic surgery

Mdm Nurshariza binti A.Aziz

0930 – 1000 Tea break

1000 – 1030 Fit for surgery programme (Pre-habilitation and CR Phase 1)

Dr Katijjahbe binti Md Ali

1030 – 1100 Managing anxiety and psychological issues following surgery

Assoc Prof Dr Suriati Mohamed Saini

1100 – 1130 Common challenges in managing cardiothoracic surgery in critical care

Dato' Dr Suneta binti Sulaiman

1130– 1200 The role and importance of nursing education and technology in multidisciplinary
professional collaboration in the CVTS Operating Theatre
Mdm Shazila binti Rosli

1200 – 1230 Awareness for future direction higher education for cardiovascular and thoracic
practitioner
Dr Sakinah binti Awang @ Harun

21
 DAILY PROGRAM
DAY 1 (14TH SEPTEMBER 2023, THURSDAY)
Pre-congress Workshop

Workshop 4: Postgraduate enclave

Theme : Cardiothoracic trainees of the future
Time : 0800 - 1300
Venue : Garden 3A, Putrajaya Marriott Hotel
Moderators : Dr. Wong Kian Boon
Dr. Kan Chan Siang

Program :
0730 – 0800 Registration

0800 – 0820 Echo and coronary angiogram

Dr Hamat Hamdi Che Hassan

0820 – 0840 Coronary CT scan and Cardiac MRI

Dr Isa Azzaki Zainal

0840 – 0900 Coronary revascularization: Basic Understanding and Surgical Techniques

Prof Dr Mohd Zamrin Dimon

0900 – 0920 Latest evidence of coronary revascularization

Prof Dr John Chan Kok Meng

0920 – 0940 Valve replacement and repair: basic understanding and surgical techniques
Dato’ Dr Faisal Ismail

0940 – 1000 Latest evidences of valve surgery

Dr Gerard Francis Lopez

1000 – 1020 Basic circulation and cardiopulmonary bypass

Dato' Dr Mohamed Hassan Ariff

1030 – 1100 Tea Break

Video presentation by Reach Surgical

1100 – 1120 Thoracic surgery: basic understanding and surgical techniques

Dato' Dr Mohd Fikri Abdullah
22
 DAILY PROGRAM
DAY 1 (14TH SEPTEMBER 2023, THURSDAY)
Pre-congress Workshop

1120 – 1140 Latest evidence of thoracic surgery

Dr Anand Sachithanandan

1140 – 1200 Basic interpretation of pulmonary imaging

Dr Nik Azuan Nik Ismail

1200 – 1220 Surgical management of malignant diseases

Dr Taufiq Abdullah

1220 – 1240 Surgical management of infective pulmonary diseases

Dr Jong Yuan Hsun

1240 – 1300 Chest wall reconstruction (Ribs fracture and pectus surgery)
Dr Harish Mithiran

23
 DAILY PROGRAM
DAY 1 (14TH SEPTEMBER 2023, THURSDAY)
Main Congress

Time : 1300 - 1645

Venue : Hall 2, Putrajaya Marriott Hotel

1300-1400 Lunch symposium – Medtronic

Advancement in Beating Heart Coronary Artery Bypass Grafting (CABG)
Prof Dr Raja Amin, Dr Ahmad Zuhdi, Dr Jong Yuan Hsun, Prof Dr Mohd Zamrin

SESSION 1
Theme : Interdisciplinary in cardiothoracic surgery
Moderators : Prof. Dr. John Chan Kok Meng
Dato’ Dr. Mohd Arif Muhammad Nor

1400 – 1430 Interdisciplinary in cardiothoracic surgery - radial vs femoral angiography for the
patient likely to need coronary surgery
Prof Dr Alistair Royse

1430 – 1500 Long term data on coronary artery revascularization - cardiologist perspective
Prof Dato’ Dr Oteh Maskon

1500 – 1530 Interdisciplinary data in lung cancer management - pulmonologist perspective

Prof Madya Dr Andrea Ban Yu-Lin

1530 – 1545 Tea Break

1545 – 1615 Advancement of chest wall reconstruction- where are we now - CTS surgeon
perspective
Dr Aneez D B Ahmed

1615 – 1645 Managing airway as a team - interdisciplinary approach

Dr Mona Zaria Binti Nasaruddin

END OF DAY 1

1900 – 2200 Faculty dinner

Putrajaya Marriott Hotel

24
 DAILY PROGRAM
DAY 2 (15TH SEPTEMBER 2023, FRIDAY)
Main Congress

Time : 0730 - 1730

Venue : Hall 2, Putrajaya Marriott Hotel

0730 – 0800 Registration

0800 – 0930 Young Investigator Award Competition

Moderator : Assoc Prof Dato’ Dr Nur Ayub Md Ali
Dr Richelle, Chua Huey Bing/Dr Syed Nasir Bin Syed Hassan
Judges : Prof Alistair Royse - Australia
Dr Aneez D B Ahmed - Singapore
Dato’ Dr. Basheer Ahamed Abdul Kareem - Malaysia

0930 – 0945 Morning break / preparation for opening ceremony

0945 – 1030 Opening Ceremony

*Please refer to Page 30 for detailed itinerary

SESSION 2
Theme: Thoracic
Moderators : Dato' Dr. Mohd Fikri Abdullah
Dr Anand Sachithanandan

1030 – 1100 Interdisciplinary approach in managing intra bronchial lesion

Dr Ng Khai Lip

1100 – 1130 Role of interventional pulmonologist in complex pleural effusion

Assoc Prof Dr Mohamed Faisal Abdul Hamid

1130 – 1200 Recent advances in managing empyema thoracic

Assist Prof Dr Boonlawat Homvises

1200 – 1230 Management of persistent air leak - FORUM

Dr Nik Nuratiqah Nik Abeed (Respiratory Physician)
Assist Prof Dr Boonlawat Homvises (Cardiothoracic Surgeon)

1230 – 1235 In remembrance of Dr Balaji Badmanaban

25
 DAILY PROGRAM
1235 – 1300 Razali Hashim Memorial Lecture
Introduction : Dato’ Dr. Basheer Ahamed Abdul Kareem
Lecture : Changing the coronary surgery landscape -Total arterial
revascularization by Prof Alistair Royse

1300 – 1400 Lunch Symposium/Friday prayer – AstraZeneca

Surgeons perspective: Adjuvant EGFR-TKI in resectable EGFRm NSCLC, for
whom and when
Prof Dr John Chan Kok Meng, Dr Anand Sachithanandan, Prof. Ho Gwo Fuang

CONTINUE SESSION 2
Moderators : Dr. Gerard Francis Lopez
Dr. Lam Hong Yoong
1400 – 1430 Options of managing stage 3 tumors – surgeon perspective
Dr Soon Sing Yang

1430 – 1500 Role of segmentectomy for lung cancer

Dr Edmund Villaroman

1500– 1530 Managing chest wall trauma– surgeon’s perspective

Dr Padungkiat Tangpiroontham

1530 – 1600 Tea Break – AstraZeneca

Neoadjuvant treatment, a good complement or an overhyped approach? From a
surgeon’s perspective
Dr Soon Sing Yang

1600– 1630 Advances of chest wall closure in deep sternal wound dehiscence post cardiac
surgery – surgeon’s perspective
Prof Dr Arman Zaharil Mat Saad

1630– 1700 Different approaches and technique in MIS thoracic surgery

Dr Aneez D B Ahmed

1700 – 1730 Current status in neoadjuvant in NSCLC

Dr Marfu'ah Nik Ezzamudden

END OF DAY 2

26
 DAILY PROGRAM
DAY 3 (16TH SEPTEMBER 2023, SATURDAY)
Main Congress

Time : 0730 - 1640

Venue : Hall 2, Putrajaya Marriott Hotel

0730 – 0800 Registration

0800 – 0930 Oral presentation Competition

Moderator : Assoc Prof Dato’ Dr Nur Ayub Md Ali/Dr. Muhammad Ishamuddin Ismail
Dr Richelle, Chua Huey Bing/Dr Syed Nasir Bin Syed Hassan
Judges : Prof Alistair Royse - Australia
Prof Dato’ Sri Dr.Jeswant Dillon - Malaysia
Dr Padungkiat Tangpiroontham- Thailand

Poster Presentation Competition

Judges : Assist Prof Dr Boonlawat - Thailand
Prof Dato’ Dr Ezani Md Taib – Malaysia
Dr Edmund Villaroman - Philippines

0930 – 1000 Morning break/Morning Symposium – Medtronics

My hands-on experience in mini-AVR with Avalus
Dr Porntawee Ariyanon & Dr Phasakorn Noiniyom

SESSION 3
Theme: Coronary Surgery
Moderators : Datuk Dr. Hamdan Leman
Dr Adli Azam Mohammad Razi
1000 – 1030 Revascularization in impaired function – cardiologist perspective
Dr Thurston Erng

1030 – 1100 Recent advancement of heart failure surgery

Prof Dato' Dr Mohamed Ezani Md Taib

27
 DAILY PROGRAM
SESSION 4
Theme: Valve Surgery
Moderators : Dr. Gerard Francis Lopez
Dr. Lam Hong Yoong

1100 – 1130 Updates for ischemic valvular surgery

Prof Dr John Chan Kok Meng

1130 – 1200 Role of interdisciplinary in valve diseases - FORUM

Datuk Dr Shaiful Azmi Yahaya, Prof Dato' Seri Dr. Jeffrey Jeswant Dillon

1200 – 1230 Recent evidence of MIS valve surgery

Prof. Dr. Shahrul Amry Hashim

1230 – 1330 Lunch symposium – Edwards Life Sciences

Role of Novel Tissue Technologies in Lifetime Management of Valvular Heart
Disease
Dato’ Dr. Basheer, Prof. Dato’ Seri Dr. Jeswant Dillon, Prof Shahrul Amry Hashim

SESSION 5
Theme: Aortic Surgery
Moderators : Dr. Ahmadi Salleh
Dato' Dr. Mohd Fikri Abdullah

1330 – 1400 Type A aortic dissection- tips and tricks

Dr. Paneer Selvam A/L Krishna Moorthy

1400 – 1430 Root, ascending aortic aneurysm

Assoc. Prof. Dr. Sivakumar Krishnasamy

1430 – 1500 Aortic arch pathology management

Dr. Paneer Selvam A/L Krishna Moorthy

1500 – 1530 Type B aortic dissection – surgery vs endovascular

Assoc. Prof. Dr. Sivakumar Krishnasamy

28
 DAILY PROGRAM
SESSION 6
Theme: Congenital Cardiac Surgery
Moderators : Dr. Ahmad Zuhdi Mamat
Dato’ Dr Abu Yamin Khamis
1530 – 1600 Application of Decellularized pericardium (CARDIOCEL) in cardiac surgery.
Dr. Nelson Alphonso

1600 – 1620 Slide tracheoplasty in Congenital tracheal stenosis and airway assessment
(Co-presentation) Dr. Siti Laura Binti Mazalan and Dr. Dayang Zuraini Sahadan

1620 – 1640 Closing ceremony, prize giving and lucky draw

END OF DAY 3

1640 – 1700 Tea Break

1700 – 1900 MATCVS BIENNIAL GENERAL MEETING & ELECTION

29
 OPENING CEREMONY
Time Agenda Venue
Hall Foyer
0915 - 0930 Arrival of VIP, honored guests, council members
VVIP suite
The arrival of
DULI YANG MAHA MULIA YANG DI-PERTUAN BESAR NEGERI SEMBILAN
TUANKU MUHRIZ IBNI ALMARHUM TUANKU MUNAWIR
welcomed by MATCVS president, council members and organizing chairman
Photo session Hotel Lobby
0930 - 0945
Hall Foyer
Meet the international speakers and Past trainees VVIP suite

Entrance to VVIP suite

Arrival of
DULI YANG MAHA MULIA YANG DI-PERTUAN BESAR NEGERI SEMBILAN
TUANKU MUHRIZ IBNI ALMARHUM TUANKU MUNAWIR
0945 - 0950 to the Banquet Hall

Commence of the Opening Ceremony

State Anthem of Negeri Sembilan and National Anthem

Doa Recitation
0950 - 1000
Ustaz Mohd Asalan Bin Roslan
Speech from the organizing chairman
1000 - 1005
Dr Muhammad Ishamuddin Ismail
Speech from the president of MATCVS
1005 - 1010
YBhg Dato’ Dr. Basheer Ahamed Abdul Kareem
Banquet hall
Royal Speech and inauguration by Putrajaya
DULI YANG MAHA MULIA YANG DI-PERTUAN BESAR NEGERI SEMBILAN Marriott Hotel
1010 - 1015 TUANKU MUHRIZ IBNI ALMARHUM TUANKU MUNAWIR

Gimmick and video montage

1015 - 1020 Presentation of Royal Gift

1020 - 1025 State Anthem of Negeri Sembilan
Hall Foyer and
1025 - 1100 Royal visit to MATCVS booths Hall 1, Marriot
Hotel, Putrajaya
1100 - Adjourn

30
 YOUNG INVESTIGATOR AWARD
BENTALL PROCEDURE: A SINGLE CENTER EXPERIENCE OVER 8 YEARS
ID 7 KM CHENG, N PRASANT, JC OOI, A SALLEH
Hospital Sultan Idris Shah Serdang

EARLY OUTCOME OF AORTIC VALVE NEOCUSPIDIZATION USING OZAKI TECHNIQUE IN THE PAEDIATRIC
POPULATION WITH RHEUMATIC HEART DISEASE: A CASE SERIES
ID 8
WS SEE, S SIVAKUMAR
Pusat Jantung Sarawak, Institut Jantung Negara

UTILIZING ENDOTHELIAL-DENUDED UMBILICAL ARTERY EX-VIVO MODEL AND PERIPHERAL BLOOD

MONONUCLEAR CELLS TOWARDS UNDERSTANDING THE MECHANISM OF VASCULAR RE-
ENDOTHELIALIZATION
ID 27
A SITI SARAH, Y MUHAMMAD DAIN, AG NUR AZURAH, ARS RAJA ZAHRATUL, MA NUR AYUB, AR MOHD
RAMZISHAM, S NADIAH
Universiti Kebangsaan Malaysia

MINIMALLY INVASIVE MITRAL VALVE REPAIR USING MODIFIED DEL NIDO CARDIOPLEGIA: IS IT BETTER?
ID 32 EY LEN, SHAHRUL A HASHIM
Universiti Malaya Medical Centre

LEFT ANTERIOR MINI-THORACOTOMY: AN ALTERNATIVE APPORACH FOR PULMONARY VALVE RE-

PLACEMENT AFTER SURGICALLY CORRECTED TEREALOGY OF FALLOT
ID 34
YL HO, K ABU YAMIN, AK BASHEER AHAMED
Penang General Hospital

OUTCOMES OF MITRAL VALVE REPAIR USING LEAFLET AUGMENTATION IN THE YOUNG

ID 42 YC CHEN, S SIVALINGAM, P SELVAM, J DILLON, A YAKUB, I GAAFFAR
Institut Jantung Negara

31
 YOUNG INVESTIGATOR AWARD
BENTALL PROCEDURE: A SINGLE CENTER EXPERIENCE OVER 8 YEARS
KM CHENG1, N PRASANT1, JC OOI1, A SALLEH1
1DEPARTMENT OF CARDIOTHORACIC SURGERY, HOSPITAL SULTAN IDRIS SHAH SERDANG, SELANGOR,
MALAYSIA

Purpose
Bentall procedure is one of several complex surgeries to treat aortic root pathologies. This intricate procedure neces-
sitates reimplantation of the coronary buttons in addition to replacement of the aortic root and valve. This paper is to
look back into our center’s Bentall procedures over the last 8 years.
Methods
Patients underwent Bentall procedure between 2016 and June 2023 were retrospectively analyzed. The primary ob-
jective was to determine the overall mortality rate. The secondary objectives were to understand the demographics of
our patients who underwent Bentall procedure, and to determine whether concomitant cardiac procedures during
Bentall surgery would affect mortality.
Results
A total of 40 Bentall procedures were done over the last 8 years with a mortality of 13 cases (mortality rate 32.5%).
Majority of patients were males (72.5%) with an average age of 40.8. Most were emergency cases (77.5%) and had a
primary pathology of aortic dissection (72.5%). Hypertension (45%), active smokers (32.5%) and preexisting renal
impairment (32.5%) were among other risk factors identified. Bentall procedure with concomitant cardiac procedures
had a higher mortality rate as compared to isolated Bentall procedure (33.8% vs 31.8%), however statistically not sig-
nificant (p=0.919).
Conclusion
Bentall procedure is a complex procedure with a significant mortality rate. However, performing additional cardiac
procedure during a Bentall operation does not increase mortality.

32
 YOUNG INVESTIGATOR AWARD
EARLY OUTCOME OF AORTIC VALVE NEOCUSPIDIZATION USING OZAKI TECHNIQUE IN THE PAEDIATRIC
POPULATION WITH RHEUMATIC HEART DISEASE: A CASE SERIES
WOAN SHIANG SEE1, SIVAKUMAR SIVALINGAM2
1 CARDIOTHORACIC SURGERY, PUSAT JANTUNG SARAWAK, MALAYSIA
2CARDIOTHORACIC SURGERY, INSTITUT JANTUNG NEGARA, MALAYSIA

Background: Aortic valve reconstruction in the pediatric population has been a surgical challenge. The ideal repair
requires an individualized approach considering aortic valve anatomy, patient size, age, and repair durability. We
aimed to analyse the short term outcomes of Aortic Valve Neocuspidization using Ozaki Technique in the paediatric
population with underlying rheumatic heart disease in Malaysia.
Methods: A retrospective analysis of all paediatric patients with chronic rheumatic aortic disease who underwent the
Ozaki procedure between 2016 and 2023 at the National Heart Institute, Malaysia. The clinical outcomes, including
mortality, surgical reinterventions, infective endocarditis, and echocardiographic measurements were assessed. Free-
dom from events was analysed using Kaplan-Meier analysis, and echocardiographic measurements were analysed
using the Wilcoxon signed rank test. A P-value of <0.05 was considered statistically significant.
Results: A total of twenty-one patients, with a median age of 11(min 10, max 15) underwent Aortic Valve Neocuspidi-
zation using Ozaki Technique for rheumatic heart disease between 2016 and 2023. All patients presented with isolat-
ed severe aortic regurgitation. Twenty patients received autologous pericardium, while one had cardiocel bovine peri-
cardium. Intraoperative findings revealed all patients had tricuspid aortic valve, with mean cusp sizes of 25mm for
RCC, LCC and NCC. Over a median follow up of 21.3 months, there was no incidence of postoperative mortality or
infective endocarditis. Nineteen patients (90.5%) remained event free. Two patients developed severe aortic stenosis
requiring aortic valve replacement at follow-up of 27 months and 32 months, respectively. Our series showed a signifi-
cant increase in annular growth during follow up echocardiographic assessments, from 21.6mm to 22.1mm (p= 0.047)
without significant decrement of coaptation height (10.2 to 9.8mm, p= 0.064).
Conclusion: Aortic Valve Neocuspidization using Ozaki Technique among paediatric patients with chronic rheumatic
aortic valve disease has shown excellent short-term outcomes. The technique allowed significant annular growth over
time in the paediatric population with stable maintenance of coaptation height.

33
 YOUNG INVESTIGATOR AWARD
UTILIZING ENDOTHELIAL-DENUDED UMBILICAL ARTERY EX-VIVO MODEL AND PERIPHERAL BLOOD MON-
ONUCLEAR CELLS TOWARDS UNDERSTANDING THE MECHANISM OF VASCULAR RE-
ENDOTHELIALIZATION
SITI SARAH AZMAN1,2, MUHAMMAD DAIN YAZID1, NUR AZURAH ABDUL GHANI3, RAJA ZAHRATUL AZMA RAJA
SABUDIN4, NUR AYUB MD ALI5,6, MOHD RAMZISHAM ABDUL RAHMAN5,6, & NADIAH SULAIMAN1*
1 CENTRE
FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, FACULTY OF MEDICINE, UNIVERSITI
KEBANGSAAN MALAYSIA, CHERAS, KUALA LUMPUR, MALAYSIA.
2 FACULTYOF APPLIED SCIENCES, UNIVERSITI TEKNOLOGI MARA, PERAK BRANCH, TAPAH CAMPUS, PE-
RAK, MALAYSIA.
3 DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY, FACULTY OF MEDICINE, UNIVERSITI KEBANGSAAN
MALAYSIA, CHERAS, KUALA LUMPUR, MALAYSIA.

A novel approach was developed to address the limited availability of autologous vessels for vascular transplantation,
leading to the advancement of tissue engineered vascular grafts (TEVG). While successful studies have been con-
ducted on large diameter vessels, small diameter vessels (< 6mm) particularly those used in coronary artery bypass
grafting (CABG) remain challenging. Cellularization of TEVG has been identified as a crucial factor influencing graft
patency, and researchers have explored various cell sources such as peripheral blood mononuclear cells (PBMC) to
be seeded on the vascular grafts. Our study aimed to establish endothelial-denuded umbilical artery ex-vivo model to
facilitate further investigations into cellular interactions and mechanisms contributing to vascular re-endothelialization.
Trypsin-EDTA was used to denude the vessel while adjusting incubation time and temperature. Effectiveness of the
method was analyzed based on the percentage EC removed from immunofluorescence images of denuded arterial
tissue section. Additionally, we examined the potential of PBMC to be recruited and adhere with the assistance of
monocyte chemoattractant protein-1 (MCP-1). The isolated PBMC were cultured in different concentration of MCP-1
and the adhered cells were counted based on immunochemistry images of cells positive for CD14 and CD11b mark-
ers. Our results indicate that chemically denuding the endothelium using trypsin-EDTA for a duration of 5 minutes at
37°C effectively removed the endothelial layer without causing damage to the underlying smooth muscle cell layer.
Moreover, when isolated PBMCs were cultured in endothelial cell growth media supplemented with 20ng/mL MCP-1,
they exhibited an increased level cellular attachment in culture. The successful development of ex-vivo model thus
provides a valuable platform to gain deeper insights into the re-endothelialization process, which holds promise for
the future development of fully functioning and patent TEVG for CABG surgery.

34
 YOUNG INVESTIGATOR AWARD
MINIMALLY INVASIVE MITRAL VALVE REPAIR USING MODIFIED DEL NIDO CARDIOPLEGIA: IS IT BETTER?
EY LEN1, SHAHRUL A HASHIM2
1 UNIVERSITI MALAYA MEDICAL CENTRE, KUALA LUMPUR, MALAYSIA

Minimally invasive mitral valve repair is technically more challenging and likely exposed to longer ischemic time. Del
Nido cardioplegia offers myocardial protection with longer re dosing interval. We report our experience using our mod-
ified del Nido cardioplegia solution compared to conventional cardioplegia in a series of minimally invasive mitral
valve repair.
We aim to investigate the efficacy and clinical results of using modified Del Nido solution (DNS) in mitral valve repair
surgery by comparing with intermittent blood cardioplegia (IBC)
A one and half year single-centre retrospective cohort study was carried out. Between January 2022 and July 2023,
58 cases of MIS valve surgery were done. Out of 58 cases, 20 adult patients who underwent primary isolated mini-
mally invasive mitral valve repair surgery with cardiopulmonary bypass (CPB) were included in this study. We used
DNS in 8 patients and IBC in 12 patients. Our primary outcomes : Aortic cross clamp time, CPB time, Post operative
and follow up ECHO. Secondary outcomes : ICU length of stay and support requirement.
The DNC group demonstrated significantly lower cardiopulmonary bypass time ( DNC = 163.38 ± 15.67 mins , IBC =
183.50 ± 54.31 mins ) , lower aortic cross-clamp time ( DNC = 110.38 ± 16.61 mins , IBC = 129.67 ± 38.94 mins ) .
However, the mitral valve pressure gradient on day 4 post op ECHO were not statistically significant between the
DNC group and IBC group ( mitral valve pressure gradient 3.85 ± 0.917 mmHg vs 4.308 ± 3.487 mmHg ; p =
0.7226 ). In DNC group, Only 2 patients had increased in severity from trivial to mild MR upon follow up, which is up
to 1 month post op. However, In IBC group, we noticed 3 out of 12 patients had increased in severity from no MR to
trivial MR up to 1 month post op follow up.
Modified DNC is a safe and effective alternative to BC for MIS MV repair surgery. It provides minimal interruption for
surgeon to give full concentration in performing mitral valve repair surgery. Despite this encouraging findings, due to
small sample numbers, validation should be done via further research or trials.

35
 YOUNG INVESTIGATOR AWARD
LEFT ANTERIOR MINI-THORACOTOMY: AN ALTERNATIVE APPORACH FOR PULMONARY VALVE REPLACE-
MENT AFTER SURGICALLY CORRECTED TEREALOGY OF FALLOT
YAN LE HO1, ABU YAMIN KHAMIS1, BASHEER AHAMED ABDUL KAREEM1
1PENANG GENERAL HOSPITAL, DEPARTMENT OF CARDIOTHORACIC SURGERY

Introduction
Tetralogy of Fallot (TOF) is one of the commonest cyanotic congenital heart diseases and its surgical outcomes have
improved dramatically over the years. However, pulmonary regurgitation (PR) remains a common sequela in patients
with surgically corrected TOF, and may lead to progressive right ventricle dilatation and dysfunction. The conventional
approach of redo-sternotomy for pulmonary valve replacement (PVR) is associated with increased operative time as
well as risks of bleeding and injury to heart and great vessels. Thus, left anterior mini-thoracotomy becomes an alter-
native approach in eliminating the risks of redo sternotomy in these patients. This series aimed to determine the out-
comes of minimally invasive pulmonary valve replacement after surgical TOF correction.

Methods
A retrospective analysis was conducted on 14 patients with severe PR post-surgical TOF correction who underwent
minimally invasive PVR in Penang General Hospital from January 2021 to January 2023.

Results
The mean age was 26±5.4 years, with male:female ratio of 1:4. Majority of patients have mild symptoms prior to sur-
gery, of whom 12 patients (85.7%) presented with NYHA 1-2, and 2 patients (14.3%) presented with NYHA 3. 10 of
the patients (71.4%) were on regular diuretics medications during presentation. All patients had severe free flow PR
with evidence of right ventricular dilatation and dysfunction. Magnetic Resonance Imaging (MRI) and computed to-
mography pulmonary artery (CTPA) were performed in these patients prior to surgery. The pulmonary arteries and
right ventricular outflow tract were all within normal range, and no residue ventricular septal defect seen. Minimally
invasive PVR was performed on all patients via left upper anterior mini-thoracotomy and femoral-femoral bypass with-
out cardioplegic arrest. The mean operative time and mean cardiopulmonary bypass time were 216±54 and
98.6±12.7minutes respectively. The average time to wean off inotropes postoperatively was 9.3±5.8hours, and no
postoperative arrhythmia and chest re-exploration was reported. The average stay in Intensive Care Unit (ICU) was
9.8±4.5hours, and the total hospital stay was 3.94±1.1 days. Only 2 patients (14.3%) required blood transfusion post-
operative. There was no paravalvular leak and no mortality during the follow-up period of up to 28 months.

Conclusion
Minimally invasive PVR after surgically correction of TOF is a safe alternative to conventional redo-sternotomy ap-
proach in patients with favorable anatomy. This approach is able to reduce the risks associated with redo-sternotomy
in particularly bleeding and injury to mediastinal structures, with additional benefit of expedite recovery and hospital
discharge. Our series has shown a safe and efficient approach in these patients with favorable outcomes.

36
 YOUNG INVESTIGATOR AWARD
OUTCOMES OF MITRAL VALVE REPAIR USING LEAFLET AUGMENTATION IN THE YOUNG
YC CHEN1, S. SIVALINGAM1, P. SELVAM1, J. DILLON1, A. YAKUB1, I. GAAFFAR2
1CARDIOTHORACIC AND VASCULAR SURGERY, NATIONAL HEART INSTITUTE MALAYSIA, KUALA LUMPUR,
MALAYSIA,
2 CLINICAL RESEARCH DEPARTMENT, NATIONAL HEART INSTITUTE MALAYSIA, KUALA LUMPUR, MALAYSIA.

Mitral valve repair is a well-known procedure for treating severe organic mitral valve pathologies with good short and
long-term outcomes. The use of leaflet augmentation in mitral repair is shown feasible and durable to increase the
leaflet surface area and reforms the coaptation zone to restore valve competence. Between January 1997 to Decem-
ber 2020 in National Heart Institute Malaysia, subgroup of 60 patients from 621 patients underwent mitral valve repair
with glutaraldehyde-treated autologous pericardial patch leaflet augmentation. Their clinical and echocardiographic
data were retrospectively analysed. The mean age of the patients was 10.9 ± 5.4 years; range 0-18 years. 57 (95%)
patients had predominant MR, while 5% had mixed mitral stenosis and mitral regurgitation (MS/MR). Out of the 60
patients, they were divided into rheumatic group 44 patients vs non-rheumatic group 16 patients (13 congenital, cardi-
omyopathy 2, IE 1). Leaflet augmentation was performed in the posterior, anterior and both leaflets in 28, 24 and 8
patients, respectively. Additional concomitant procedures were AV repair 4 (6.7%), AVR 3 (5%), TAP 22 (36.7%).
90% of the repairs were stabilized with annuloplasty rings. The follow-up was 87% complete with a mean follow-up of
8.7 ± 5 years (range 0-25.1 years). There was 8 mortalities (14%) in this series, early and late mortality of 3 and 5
patients respectively. At the latest follow-up, the MR grade was none/trivial in 71.4%, mild in 21.4%, moderate in 1.6%
and severe in 1.6% of patients. The mean peak gradients of mitral valve was of a mean of 8.1 ± 5.5 mmHg. Three
patients had redo mitral surgery. The presence of atrial fibrillation and pleural effusion were found to be significant
predictors of mortality and those without ring implantation significantly contributed to mitral valve deterioration. Free-
dom of mortality, reoperation and valve failure were 90.7%, 94.4% and 73.1% respectively at 10 years. The outcomes
of mitral repair in the young were in keeping with those reported in previous studies. We demonstrated leaflet aug-
mentation as a feasible technique in the armamentarium of mitral valve repair with reasonable outcomes.

37
 ORAL PRESENTATIONS
RARE CASE SERIES: RESECTION OF RENAL CELL CARCINOMA WITH LEVEL IV INFERIOR VENA CAVA
THROMBUS UNDER CARDIOPULMONARY BYPASS. IS IT WORTH SAVING?
ID 9
MOHD FADZLI, F THOMAS, S AHMADI
Hospital Sultan Idris Shah Serdang, Hospital UiTM

REVASCULARISATION VIA LEFT ANTERIOR THORACOTOMY: A HYBRID SOLUTION?

ID 10 Z ZHAFRI, A MUHAMMAD IBRAHIM, N ASHVIN KRISHNA, H SHAHRUL AMRY
University Malaya Medical Centre

SINGLE CENTER EXPERIENCE ON ENDOVASCULAR INTERVENTION FOR TYPE B AORTIC DISSECTION

ID 14 T ARVIN, H SYAKIR, Z ISMAZIZI
Institut Jantung Negara

HYDROXYTYROSOL PREVENTS INTIMAL HYPERPLASIA IN VASCULAR IN VITRO AND EX VIVO ORGAN

CULTURE MODEL
ID 18 V UBASHINI, Y MUHAMMAD DAIN, MA NUR AYUB, H HAIRULFAIZI, I MUHAMMAD ISHAMUDDIN, AR MOHD
RAMZISHAM, S NADIAH
Universiti Kebangsaan Malaysia

COMPARISION OF INTRAOPERATIVE AND POSTOPERATIVE CHARACTERISTICS USING ANTEGRADE

CARDIOPLEGIA ALONE VERSUS ANTEGRADE COMBINED WITH VEIN CARDIOPLEGIA IN ON-PUMP COR-
ID 23 ONARY ARTERY BYPASS GRAFT SURGERY
S GURPREET, M IZZAD IZZUDDIN, SJ VENDARGON, GSH SYED RASUL
Hospital Sultanah Aminah

OUTCOMES OF RADICAL PERICARDECTOMY IN CONSTRICITVE PERICARDITIS

ID 35 YL HO, K ABU YAMIN, AK BASHEER AHAMED
Penang General Hospital

REDO CARDIAC SURGERY IN HOSPITAL QUEEN ELIZABETH 2 – A SINGLE CENTRE EXPERIENCE

ID 38 M AZRI, CC CHUA, T DAVID
Hospital Queen Elizabeth II

NAVIGATING THE CHALLENGES OF NEONATAL AND PREMATURE PATENT DUCTUS ARTERIOSUS CLO-
SURE THROUGH CARDIAC SURGICAL AND TRANSCATHETER INNOVATIONS
ID 43
N DHIVAN NAIDU, P ANANBABU, M SITI LAURA, YK OOI
Hospital Sultan Idris Shah Serdang

38
 ORAL PRESENTATIONS
RARE CASE SERIES : RESECTION OF RENAL CELL CARCINOMA WITH LEVEL IV INFERIOR VENA CAVA
THROMBUS UNDER CARDIOPULMONARY BYPASS. IS IT WORTH SAVING?
MOHD FADZLI1, THOMAS FRANCIS2, AHMADI SALLEH3
1 HOSPITAL SULTAN IDRIS SHAH SERDANG, SELANGOR, MALAYSIA
2 HOSPITAL UiTM SUNGAI BULOH, SELANGOR, MALAYSIA

Introduction: The primary objective of the series was to investigate the outcome of surgical management of Renal
Cell Carcinoma (RCC) with level IV Inferior Vena Cava (IVC) thrombus using cardiopulmonary bypass (CPB).

Methods: A retrospective analysis was conducted on four RCC patients with level IV IVC thrombus who underwent
radical nephrectomy and IVC thrombus resection under CPB with either deep hypothermic circulatory arrest (DHCA)
or low flow cardiopulmonary bypass (LFCPB) between January 2006 until December 2022 in single tertiary referral
center. Perioperative variables, such as CPB time, mortality, morbidity, Fuhrman Grade, and pre-operative distant
metastasis, were documented and analyzed.

Results: Four patients (mean age 53.5 years) underwent surgery under CPB with either DHCA or LFCPB. Mean CPB
time was 150.3minutes ( ± 19.1 SD). Among the four patients, three underwent DHCA (mean duration 30 minutes)
and another one patient underwent the LFCPB technique (39 minutes). Three out of the four had Fuhrman Grade 4
and presented with pre-operative distant metastasis and lymph nodes involvement. There were no perioperative mor-
tality, stroke or major intraoperative complications reported in this series. However, these three patients exhibited dis-
ease progression within a year post surgery, with a mean progression-free survival (PFS) of 5 months. The only pa-
tient with Fuhrman Grade 2 and no pre operative distant metastasis remained disease-free for over 53 months after
the surgery.

Conclusion: The use of CPB with DHCA or LFCPB appears to be a relatively safe surgical approach for treating
RCC with level IV IVC thrombus. Nevertheless, careful pre-operative patient selection and ensuring patient under-
standing of disease progression are crucial for enhancing the patient’s overall quality of life.

39
 ORAL PRESENTATIONS
REVASCULARISATION VIA LEFT ANTERIOR THORACOTOMY: A HYBRID SOLUTION?
ZHAFRI ZULKIFLI, MUHAMMAD IBRAHIM AZMI, ASHVIN KRISHNA NAIR, SHAHRUL AMRY HASHIM.
UNIVERSITI MALAYA MEDICAL CENTRE, KUALA LUMPUR, MALAYSIA.

Objective: Coronary revascularisation via anterior thoracotomy (TCRAT) replicability has the capacity as an excellent
sternal sparing approach for hybrid coronary revascularisation. We aim to demonstrate this potential by examining the
quality of the grafts to left anterior descending artery (LAD) in our TCRAT cases.

Methods: Our practice involves harvesting LIMA with direct vision through left anterior thoracotomy using ultrasonic
energy device. Cardiopulmonary bypass was established with peripheral cannulation and coronary anastomosis was
done with arrested heart using modified del Nido cardioplegia solution. We analysed the transit time flow measure-
ment (TTFM) of the grafts to LAD in our series of 50 cases between January 2023 and July 2023. We excluded cases
without graft to LAD. TTFM parameters recorded were flow, pulsatility index (PI), and diastolic filling (DF). These pa-
rameters were recorded after completion of protamine infusion. We also recorded cardiopulmonary bypass (CPB)
time, aortic cross clamp (XC) time, average XC (aXC) time per graft where aXC = XC/n.

Results: 47 out of 50 cases had grafts to LAD. The average Euroscore II of our series was 0.99% with the average
LVEF of 57.7%. From our series there were 130 grafts in total with the average of 2.76 grafts per case. There were 47
grafts to LAD. We used in-situ left internal mammary artery (LIMA) in 44 (93.6%) cases, free LIMA in 1 (2.1%) case,
and radial artery in 2 (4.2%) cases. 95.7% (n=45) of the grafts exhibit flow ≥ 15 ml/min with the remaining two grafts
had flow of 11 ml/min and 13 ml/min. 100% (n=47) of the grafts to LAD had excellent PI between 0.1 - 3.0. The mean
CPB time was 166.48 minutes and the mean XC time was 80.7 minutes. The aXC time was 29.23 minutes.

Conclusion: TCRAT’s replicability increases adoption of sternal sparing CABG. Our series revealed excellent TTFM
measurements and short operating time of a single graft demonstrated TCRAT’s ability in addressing single proximal
LAD disease with potential adaptation in hybrid revascularisation in selected cases through interdisciplinary consen-
sus.

40
 ORAL PRESENTATIONS
SINGLE CENTER EXPERIENCE ON ENDOVASCULAR INTERVENTION FOR TYPE B AORTIC DISSECTION
ARVIN THIRUCHELVAM1, SYAKIR HASENAN1, ISMAZIZI ZAHARUDIN1
1 DEPARTMENT OF CARDIOTHORACIC & VASCULAR SURGERY, NATIONAL HEART INSTITUE, KUALA LUM-
PUR, MALAYSIA

Purpose: This study was undertaken to evaluate the single center experience of endovascular intervention for Type B
aortic dissection

Methods: Data were retrospectively analyzed in 10 consecutive patients over the past 2 years (2021-2022) who had
an endovascular intervention in IJN for Type B Aortic dissection. Patients’ demographic, clinical and procedural data
including preoperative characteristics and operative details were collected. Primary outcomes evaluated were mortali-
ty, stroke, spinal cord ischemia, vocal cord palsy and vascular access complications.

Results: There were 10 patients who had Stanford Type B aortic dissection who underwent thoracic endovascular
aortic repair (TEVAR). 1(10%) presented with acute aortic dissection, 6(60%) in the subacute stage and 3(30%) in the
chronic stage. The majority of patients were male (90%), with a mean age of 61.5 ± 19.5years. TEVAR was per-
formed till different zones, with no patients in Zone 0, 20% in Zone 1, 30% in Zone 2, 30% in Zone 3 and 20% in Zone
4 Aorta. While 50% of patients did not require any bypass for the neck vessels, 30% needed a single neck vessel
chimney and 20% required surgical bypass. Average post operative hospital stay was 5.4 days (ranging 2-19 days).
Postoperative vocal cord palsy occurred in 1 patient (10%) but no cases of vascular access injury, spinal hypoperfu-
sion, cerebrovascular accident or mortality is reported in our study.

Conclusion: Our study demonstrates that endovascular intervention with TEVAR for Type B aortic dissection in IJN
resulted in favorable outcomes with low incidence of complications. However, given the small sample size, further
studies with larger cohorts and longer duration of study is required to validate these findings

41
 ORAL PRESENTATIONS
HYDROXYTYROSOL PREVENTS INTIMAL HYPERPLASIA IN VASCULAR IN VITRO AND EX VIVO ORGAN
CULTURE MODEL
UBASHINI VIJAKUMARAN1, MUHAMMAD DAIN YAZID1, NUR AYUB MD ALI2,3, HAIRULFAIZI HARON2,3, MUHAM-
MAD ISHAMUDDIN ISMAIL2, MOHD RAMZISHAM ABDUL RAHMAN 2,3, NADIAH SULAIMAN1
1CENTRE OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, UNIVERSITI KEBANGSAAN MALAYSIA
MEDICAL CENTRE, KUALA LUMPUR, MALAYSIA,
2DEPARTMENT OF SURGERY, HOSPITAL CANSELOR TUANKU MUKHRIZ, UNIVERSITI KEBANGSAAN MALAY-
SIA MEDICAL CENTRE, KUALA LUMPUR, MALAYSIA,
3PUSATJANTUNG DAN PARU-PARU, HOSPITAL CANSELOR TUANKU MUHRIZ, JALAN YAACOB LATIF, BAN-
DAR TUN RAZAK, KUALA LUMPUR

Background: Intimal hyperplasia (IH) is a luminal vascular thickening due to excessive proliferation and migration of
smooth muscle cells (SMC). IH is the main reason for post-coronary artery bypass grafting (CABG) and percutaneous
coronary intervention (PCI) restenosis. The use of antiproliferative drugs, such as paclitaxel-eluting Drug Eluting
Stents (DES), successfully inhibits SMC proliferation, but they delay reendothelisation. The formation of oxidative
stress also further worsens endothelial inflammation and vascular remodelling. Hence, utilising Hydroxytyrosol, an
antioxidant extracted from olive which is well studied for its anti-inflammatory and antiproliferative effects, potentially
circumvents IH development. The hypothesis is tested through in vitro effect of different HT doses that potentially pro-
mote endothelial cells (EC) but inhibit SMC proliferation.

Method: EC and SMC were collected from surplus saphenous veins of patients undergoing CABG surgery at Hospi-
tal Canselor Tuanku Mukhriz (HCTM). Cell cytotoxicity and proliferation were detected through (3-(4,5-
dimethylthazolk-2-yl)-2,5-diphenyl tetrazolium bromide) (MTT) and 5-ethynyl-2′-deoxyuridine (EDU) assay. Reactive
oxygen species (ROS) production was assessed through a 2'-7'-Dichlorodihydrofluorescein diacetate (DCFDA) assay.
HT effect on cell migration validated using wound healing and Boyden chamber assay. Cell cycle analysis is done
through flow cytometry by staining DNA. Exvivo model was analysed using histological and immunohistochemistry
staining. Lastly, the signalling pathways were elucidated via western blotting.

Results: We found 50mM of HT significantly inhibited PDGF-induced excessive proliferation, migration, cell cycle and
chemotaxis effect in vitro in PDGF-BB-induced SMC by downregulating PI3K/AKT and upregulating NRF2/HO-1, anti-
oxidant pathway. At the same time, HT preserves EC viability, proliferation, and migration ability via activating the
AKT, cell survival and Nrf2/HO-1 antioxidant pathway in vitro. Concurrently, IH ex vivo model was set up by culturing
saphenous vein rings with and without HT treatment for up to 21 days. Cellular proliferation increased 62% from day 5
to day 21. HT reduced the proliferation index by half, 55.1%. The suppression of proliferation is mediated by the inac-
tivation of the AKT pathway, vimentin a synthetic phenotype marker and the upregulation of HO-1 expression.

Conclusion: Our study revealed hydroxytyrosol's dual and cell-specific action in SMCs and ECs as an antioxidant
and antiproliferative agent. These findings support the therapeutic potential of HT in preventing intimal hyperplasia
and reendothelisation of vascular grafts.

42
 ORAL PRESENTATIONS
COMPARISION OF INTRAOPERATIVE AND POSTOPERATIVE CHARACTERISTICS USING ANTEGRADE
CARDIOPLEGIA ALONE VERSUS ANTEGRADE COMBINED WITH VEIN CARDIOPLEGIA IN ON-PUMP
CORONARY ARTERY BYPASS GRAFT SURGERY
GURPREET SINGH1, IZZAD IZZUDDIN MUSTAFFA1, VENDARGON SJ1, SYED RASUL BIN G. SYED HAMID1
1DEPARTMENT OF CARDIOTHORACIC SURGERY, HOSPITAL SULTANAH AMINAH, JOHOR BAHRU, MALAYSIA

Introduction:
Cardioplegia is an integral component of myocardial protection. Standard delivery of cardioplegia includes antegrade
and retrograde method. Retrograde technique may cause injury to the coronary sinus while antegrade alone may be
inadequate especially delivery of cardioplegia through very stenotic vessels. Therefore, in this study we compare in-
traoperative and postoperative outcomes using antegrade cardioplegia alone against combination of antegrade and
vein cardioplegia in on pump coronary artery bypass graft surgery.

Methodology:
This is a cross sectional retrospective study. Two groups of patients (antegrade combined with vein cardioplegia-
study group and antegrade cardioplegia alone- control group) were studied. The study group consists of 42 patients
while the control group consists of 39 patients. Study population are patients aged between 30-80 years old between
1 January 2019 and 30 April 2023. Intraoperative characteristics such as cardiopulmonary bypass time, aortic cross
clamp time, cardioplegia volume and postoperative characteristics such as hospital stay, mortality, intra aortic balloon
pump insertion, chest reopen for bleeding and postoperative arrythmias were compared.

Results:
The results of this study showed that cardiopulmonary bypass time, hospital stay, mortality, postoperative IABP inser-
tion and postoperative arrhythmia rate for both groups were similar, however not statistically significant. Therefore,
there is no statistical relationship between both groups to show causality.

Conclusion:
The primary finding of this study shows that antegrade combined with vein cardioplegia is neither superior nor inferior
compared antegrade cardioplegia alone in terms of myocardial protection.

43
 ORAL PRESENTATIONS
OUTCOMES OF RADICAL PERICARDECTOMY IN CONSTRICITVE PERICARDITIS
YAN LE HO1, ABU YAMIN KHAMIS1, BASHEER AHAMED ABDUL KAREEM1
1PENANG GENERAL HOSPITAL, DEPARTMENT OF CARDIOTHORACIC SURGERY

Introduction: Constructive pericarditis is a rare but potentially disabling and fatal disease. The pathology is often
considered as the final stage of chronic inflammation characterized by fibrous thickening and calcification of the peri-
cardium. This process eventually leads to impairment of diastolic filling, reduces cardiac output and ultimately results
in cardiac failure. Early pericardiectomy with complete decortication provides good symptomatic relief and is often the
treatment of choice for constrictive pericarditis.

Methods: A retrospective analysis was conducted on 4 patients with constrictive pericarditis who underwent radical
pericardiectomy from January 2021 to July 2023 in Penang General Hospital. The demographic factors, characteris-
tics of constrictive pericarditis and outcomes of surgery were analyzed.

Results: The mean age was 46.2±12.3 years and 3 patients were male. Etiology of constrictive pericarditis was tu-
berculosis in 2 patients, both of whom had previous pulmonary tuberculosis but completed treatment, uremia in 1 pa-
tient with end stage renal failure, and idiopathic in another patient. All patients were admitted for overt symptoms of
heart failure, with progressive worsening of dyspnea, orthopnea and reduced effort tolerance. All of them had liver
transaminitis with coagulopathy, and also presented with acute kidney injury. Contrast-enhanced CT and cardiac
magnetic resonance scan were performed on these patients, delineating the extend of pericarditis. Median sternoto-
my and radical pericardiectomy with cardiopulmonary bypass were performed on all 4 patients. 1 of the patients had
severe mitral regurgitation and another patient had severe tricuspid regurgitation, in which concomitant mitral and
tricuspid valve repair were performed on these 2 patients respectively. The length of ICU and hospital stay was
4.5±1.3 and 11.8±3.8 days respectively. One of the patients developed low output state but improved with intra-aortic
balloon pump and had delayed chest closure. All patients were discharged well. They reported to have improvement
in functional status with all patients being in NYHA class 1-2 during their follow up for up to 2 years. There was no
mortality reported and no patient developed recurrence pericarditis requiring repeat surgery.

Conclusion: Constrictive pericarditis, although uncommon, command substantial clinical interest because of the per-
ceived potential for surgical care. The pathology is often associated with high morbidity and mortality rate, and its
management remains challenging in both surgical technique and optimized medical therapy. Nonetheless, early peri-
cardiectomy in patients with favorable status is recommended to improve functional outcomes and survivability.

44
 ORAL PRESENTATIONS
REDO CARDIAC SURGERY IN HOSPITAL QUEEN ELIZABETH 2 – A SINGLE CENTRE EXPERIENCE
AZRI MARICAN1, CHUA CHEN CHEN1, DAVID TANG1
1 HOSPITAL QUEEN ELIZABETH 2, KOTA KINABALU, SABAH

Introduction:
Redo cardiac surgeries are associated with a high rate of morbidity and mortality. This a retrospective observational
study looking at the major adverse cardiac events after redo surgeries at our centre.

Methods:
We identified consecutive adults undergoing repeat median sternotomy for redo cardiac surgery at our centre either
elective or emergency from January 2013 until April 2023. Total of 80 patients underwent isolated re-operative coro-
nary artery bypass grafting, aortic and/or mitral valve replacement, pulmonary valve replacement, tricuspid annulo-
plasty and combination of these procedures. The operative notes and perioperative outcomes were reviewed.

Results:
42% patients are male with mean age of 37.5 (interquartile range 26-46). 70% of the redo cardiac surgeries indicated
for valvular disease where 42% of these are redo mitral valve surgeries and tricuspid annuloplasty, and 20% of these
involves aortic and mitral valve surgeries. Only 10% involves redo aortic surgeries. 82% are elective surgery and 59%
performed using central aortic cannulation The mean logistic EuroSCORE II is 10.23%(±SD14.13). Mean cardiopul-
monary bypass time is 235.52 (±SD93.86) minutes and cross-clamped time is 142.99 (±SD59.94) minutes. Perioper-
ative stroke 1.25%, new onset acute kidney injury 7.5% and reopen rates 5%. Sternal wound infection 6.25%. Mean
ICU stay 7.2 days and length of hospital stay 25.75 days. Our 30-days mortality was 20%.

Conclusion:
The mortality rate was 20% compared to another centre which ranging from 3.5% in highly experienced centre and up
to 26% with re-entry injury. The high mortality rate may be due to the majority of redo cardiac surgeries involved 2 or
more valves surgeries.

45
 ORAL PRESENTATIONS
NAVIGATING THE CHALLENGES OF NEONATAL AND PREMATURE PATENT DUCTUS ARTERIOSUS
CLOSURE THROUGH CARDIAC SURGICAL AND TRANSCATHETER INNOVATIONS
DHIVAN NAIDU NOKANAIDU1 ,ANANBABU PALANIAPPAN1 ,SITI LAURA MAZALAN1 ,OOI YK2
1DEPARTMENT CARDIOTHORACIC SURGERY ,HOSPITAL SULTAN IDRIS SHAH,MALAYSIA
2PAEDIATRIC CARDIOLOGY ,HOSPITAL SULTAN IDRIS SHAH,MALAYSIA

Background: In full term infants, Ductus Arteriosus (DA) undergoes complete closure at 96 hours of life.In Pre-
term infants,structural and physiological immaturity of the ductus is often associated with delayed closure and DA
remains patent at the equivalent time of term gestation.Incidence of patent ductus arteriosus (PDA) is as high as 60%
in preterm infants and 80% in low birth weight neonates <1200 g at birth while premature babies < 26w gestational
age had PDA beyond 2 months postnatally.Spontaneous closure in extremely low birth weight (ELBW) infants are at
15%.

Methods: Single institution,Retrospective study in prematures,neonates and infants diagnosed with PDA. Cohort of
patients grouped into Surgical Ligation (SL) or Transcatheter Occlusion (TC).

Results: Comparative analysis of 5 year data (2019 - 2023) with sample size of 142 patients in which Group 1(SL):
Surgical ligation n= 63 (44%), Group2 (TC): Transcatheter occlusion n=79 (55%) with neonates (n=55) underwent
(SL=41,TC =14).Patient above the age of 1 year old has been excluded.Comparative outcomes between 2 groups
analysed on inpatient Mortality rate,Complete PDA occlusion rate,Residual PDA flow rate,Morbidity rate in both neo-
natal and premature population

Conclusion: The complications arising from PDA are -due to redirection of oxygen-rich blood away from vital organs
through the PDA to the pulmonary artery. This choreography results in a symphony of systemic hypoperfu-
sion,pulmonary overcirculation and neonatal pulmonary hypertension which orchestrates a crescendo of end-organ
damage such as necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), neonatal chronic lung disease
(CLD), retinopathy of prematurity (ROP), and intraventricular hemorrhage (IVH),with the haunting shadow of mortality
looming. Amidst the evolving melody of medical technology, the decision between surgical and transcatheter closure
techniques has transformed. However, this complex composition prompts a call for a more elaborate interdisciplinary
duet a holistic comparison of their clinical outcomes, a spotlight that deserves to shine particularly on the canvas of
premature infants.

46
 POSTER PRESENTATIONS
IS MODIFIED DEL NIDO CARDIOPLEGIA A SAFE ALTERNATIVE TO CONVENTIONAL BLOOD CARDIOPLE-
GIA IN AORTIC SURGERY?
ID 2
PH TAN, H SHAHRUL AMRY
Universiti Malaya Medical Centre
WHAT WAS THE FIRST RESPONSE TO LOW URINE OUTPUT POST CARDIAC SURGERY – A RETROSPEC-
TIVE EXPLORATORY ANALYSIS
ID 3
CP PAU, AM YUNUS, I FARIZA
Institut Jantung Negara

OVERCOMING VENTRICULAR WALL PERFORATION IN PACEMAKER IMPLANTATION - TWO INTRIGUING

CASES
ID 6
D NURHANIS, FL GERARD
Hospital Raja Perempuan Zainab II

EMERGENCY TEVAR FOR TRAUMATIC THORACIC AORTIC INJURY: A CASE REPORT

ID 12 Z ZULKIFLI, F RADUAN, S KRISHNASAMY
Universiti Malaya Medical Centre

INDOCYANINE GREEN FLUORESCENCE-GUIDED UNIPORTAL VATS PULMONARY WEDGE RESECTION IN

A CHILD WITH CONGENITAL PULMONARY AIRWAY MALFORMATION
ID 13
Z ZULKIFLI, S KRISHNASAMY, M MENON, TCY DAVID, LPS EMMY
Universiti Malaya Medical Centre

ZIP & GO: A CASE SERIES OF MANAGING SUPERFICIAL STERNAL WOUND DEHISCENCE
ID 15 PS LAW, MATTHEW WONG, MJM SHAHKIZZA, LJ CHEONG, SY SOON, YH JONG
Sarawak Heart Centre
EARLY EXPERIENCE IN RADIAL ARTERY HARVESTING BY PERI-OPERATIVE SURGEON ASSISTANT – A
SINGLE-CENTER STUDY
ID 16
B MUHAMMAD ASHRAFF, K MUHAMAD ZAHID, KB WONG, S SHAHRUL AKMAL, MY ALWI
Institut Jantung Negara
A NEEDLE'S MISDIRECTION: UNRAVELLING VASCULAR INJURIES IN MALPOSITIONED CENTRAL
VENOUS CATHETERS AND SAFE REMOVAL APPROACHES
ID 17
S HAN, A SALLEH, A KHALIS, M ARIF M NOR
Hospital Sultan Idris Shah Serdang
CLINICAL PSYCHOMETRIC PROPERTIES OF UNSUPPORTED UPPER-LIMB EXERCISE TEST IN MEASUR-
ING UPPER LIMB FUNCTION AFTER MEDIAN STERNOTOMY
ID 19 MA NUR AYUB, EA DOA, MR MOHD RAMZISHAM, A SURIAH, I AZRI, I NURDIYANA, R COLIN, R ALISTAIR, H
HAIRULFAIZI, I MUHAMAD ISHAMUDIN, AM MOHD RIZAL, MA KATIJJAHBE
Universiti Kebangsaan Malaysia
STERNAL ZIPFIX SYSTEM: A RETROSPECTIVE STUDY ON THE POLYMER CABLE TIE CLOSURE OF THE
STERNUM
ID 20
J Y NG, I M ISHAMUDDIN, M A NUR AYUB, H HAIROLFAIZI, A R M RAMZISHAM
Universiti Kebangsaan Malaysia

47
 POSTER PRESENTATIONS
DUMBBELL TUMOUR: A COMBINED INTRATHORACIC AND INTRASPINAL APPROACH TO A NEUROGENIC
TUMOUR
ID 21
J Y NG, A R KHAIRUL ANWAR, H HAIROLFAIZI, I M ISHAMUDDIN, M A NUR AYUB, A R M RAMZISHAM
Universiti Kebangsaan Malaysia

COMPARISON OF SUTURELESS VALVE VERSUS CONVENTIONAL STENTED VALVE IN PATIENT UNDER-

GOING BIOPROSTHETIC AORTIC VALVE REPLACEMENT WITH CONCOMITANT CARDIAC PROCEDURE
ID 22
S AHMAD MAHIR, D JESWANT
Institut Jantung Negara

A CASE REPORT: MONOSTATIC FIBROUS DYSPLASIA OF THE RIB

ID 24 A AIZAT, FL GERARD, MY MUHD AFIF
Hospital Raja Perempuan Zainab II

CASE REPORT: EXTRAPLEURAL PLEURECTOMY/ DECORTICATION AND RECONSTRUCTION OF DIAPH-

RAGM, PERICARDIUM AND CHEST WALL FOR LEFT MALIGNANT PLEURAL MESOTHELIOMA
ID 25
TS CHANG, PS LAW, S KRISHNASAMY
Universiti Malaya
CASE SERIES: SURGICAL STRATEGY IN EXCISION OF BRONCHOGENIC CYSTS AT UNIVERSITY MALAYA
MEDICAL CENTRE
ID 26
TS CHANG, M MENON, S KRISHNASAMY
Universiti Malaya

CORONARY ARTERY BYPASS GRAFT IN FACTOR XII DEFICIENCY PATIENT

ID 29 A HARITH AMIRIZAL, A MUHAMMAD IBRAHIM, KN ASHVIN
Universiti Malaya Medical Centre

5 -YEAR EXPERIENCE OF UNIPORTAL VIDEO ASSISTED THORACOSCOPIC SURGERY IN MALAYSIA

ID 30 A HARITH AMIRIZAL, XY TOH, K SIVAKUMAR
Universiti Malaya Medical Centre

STANDFORD A WITH NERI TO THE CORONARY: A SURGEON’S HORROR STORY

ID 33 A HARITH AMIRIZAL, A MUHAMMAD IBRAHIM, KN ASHVIN, H SHAHRUL AMRY
Universiti Malaya Medical Centre

GRAFT QUANTITY AND QUALITY COMPARISON BETWEEN TCRAT AND CABG

ID 36 P SEKARAN, M MENON, SA HASHIM
Universiti Malaya

AORTIC IMAGING CHANGING THE CORONARY REVASCULARISATION FRONTIER

ID 37 A HARITH AMIRIZAL, A MUHAMMAD IBRAHIM, KN ASHVIN, H SHAHRUL AMRY
Universiti Malaya Medical Centre

48
 POSTER PRESENTATIONS
SUCCESSFUL SURGICAL MANAGEMENT OF POSTERIOR MEDIASTINAL SCHWANNOMA: A COMPREHEN-
SIVE CASE STUDY
ID 39
I AZRIL, A ALIF, H NAJWA, S ANAS
Universiti Teknologi Mara, Hospital Tengku Ampuan Afzan

RESOLUTION OF EMPYEMA AND SUBPHRENIC ABSCESS: A CASE REPORT EMPHASIZING EARLY DIAG-
NOSIS AND TREATMENT
ID 40
I AZRIL, A ALIF, H NAJWA, I FAISAL
Universiti Teknologi Mara, Hospital Tengku Ampuan Afzan

FOLLOW-UP STUDY ON EARLY DAPT ADMINISTRATION AT 6 HOURS POST ISOLATED CABG

ID 41 YC CHEN, K ANUAR, E TAIB, A YUNUS, I GAAFFAR
Institut Jantung Negara

APPLICATION OF “NEOVEIL SHEET” IN THE TREATMENT OF AIR LEAK IN THORACIC CASES

ID 44 S DALVINDER, M FAUZI J, AK BASHEER AHAMED, K ABU YAMIN, K SOTHEENATHAN
Hospital Pulau Pinang

AN ERA OF MODIFIED BLALOCK-THOMAS-TAUSSIG SHUNTS (MBTTS) IN TETRALOGY OF FALLOT (TOF):

A 10 YEAR RETROSPECTIVE STUDY OF PULMONARY ARTERY GROWTH AND ITS OUTCOME IN HOSPI-
ID 45 TAL SULTAN IDRIS SHAH, MALAYSIA
CE NG, CS KAN, M SITI LAURA, L HAMDAN
Hospital Sultan Idris Shah Serdang
SUCCESSFUL REMOVAL OF A HUGE RUPTURED MEDIASTINAL TERATOMA WITH MEDIASTINITIS IN A 17
YEARS OLD FEMALE
ID 47
M IZZAD, V SIMON, SYED RASUL
Hospital Sultanah Aminah
PICO™ SYSTEM USED IN SAPHENOUS VEIN GRAFT WOUND BREAKDOWN FOLLOWING CORONARY AR-
TERY BYPASS GRAFTING WITH SILVER NANOPARTICLES SLOW RELEASE DRESSING
ID 48
MA NOR ANITH, R MURSHIDAH, MR ADLI AZAM
Universiti Pertahanan Nasional Malaysia, Universiti Teknologi Mara
LATE PRESENTATION OF PULMONARY SEQUESTRATION WITH CONCOMITTANT BRONCHOGENIC CYST
IN ADULT. A CASE REPORT
ID 49
MA NOR ANITH, D MOHD ZAMRIN
Universiti Pertahanan Nasional Malaysia, Universiti Teknologi Mara
ANOMALOUS ORIGIN AND COURSE OF LEFT ANTERIOR DESCENDING CORONARY ARTERY : A RARE
CASE ENCOUNTER
ID 50
AR AZUWANI, K ABU YAMIN
Hospital Pulau Pinang

A CASE REPORT: A RARE CHEST WALL UNDIFFERENTIATED PLEOMORPHIC SARCOMA

ID 51 M SUFRIN, GF LOPEZ, S NORAZIAH
Hospital Raja Perempuan Zainab II

49
 POSTER PRESENTATIONS
OPTIMIZED OUTCOMES UTILIZING CUSTODIAL HTK SOLUTION IN CARDIAC SURGERY INVOLVING IMPAI-
RED LV FUNCTION: INSIGHTS FROM UITM'S EXPERIENCE.
ID 52
TM SYUKRI, ANAS KASRAN, RM RAJA AMIN
Universiti Teknologi Mara

CLINICAL PREDICTORS OF TRACHEOSTOMY POST CARDIAC SURGERY IN ADULT PATIENT: LARGE SIN-
GLE CENTRE ANALYSIS 2015 TO 2023
ID 53
RAJA BURHANUDEEN, D JESWANT
Institut Jantung Negara

MIDTERM REVIEW OF CONCOMITANT COX-MAZE IV(CRYO-RF) PROCEDURE IN PATIENTS UNDERGOING

ELECTIVE CARDIAC SURGERY: A SINGLE SURGEON CENTRE EXPERIENCE
ID 54
DT SHANNON, D TANG
Hospital Queen Elizabeth II

A CASE OF ACUTE PULMUNARY CEMENT EMBOLISM MANAGED THROUGH SURGICAL INTERVENTION

ID 55 T THANISSWARAN, D TANG
Hospital Queen Elizabeth II

OUTCOMES AND PREDICTORS OF IN-HOSPITAL MORTALITY IN INFECTIVE ENDOCARDITIS PATENTS

REQUIRING SURGERY
ID 56 N HAFIZAH ZAILANI, N AZIAH ISMAIL, AB FATAHIYAH, YTW DAVID, AS MAIZATU, M EZANI TAIB, ALWI
YUNUS
Institut Jantung Negara
A CHALLENGING CASE OF AN ECTOPIC VENOUS CATHETER INSERTION: TIPS AND RECOMMENDA-
TIONS
ID 57
N HAFIZAH ZAILANI, M ABID AMIR, ISQANDAR ADNAN, RA RAJA MOKHTAR
Universiti Teknologi Mara
PERIOPERATIVE MANAGEMENT OF ANTIPHOSPHOLIPID SYNDROME (APLS) PATIENT UNDERGOING
CORONARY ARTERY BYPASS GRAFT SURGERY (CABG)
ID 58
BZ NAZURAH, D MOHD ZAMRIN, H JUITA
Universiti Teknologi Mara

AN ENTANGLED SWAN GANZ CATHETER; AN UNCOMMON COMPLICATION

ID 59 WM AFHAM, HH AIMATNUDDIN, AHMAD ZUHDI
Universiti Teknologi Mara

10 YEARS EXPERIENCE SINUS OF VALSAVA ANEURYSM REPAIR

ID 60 H ABDULLAH, AR SANUSI
Institut Jantung Negara

TRAUMATIC AORTIC VALVE RUPTURE: DON’T MISS IT!

ID 61 K RAANIDARSENI, MR ABDUL RASHID, K SOTHEENATHAN, K ABU YAMIN, AK BASHEER AHAMED
Hospital Pulau Pinang

50
 POSTER PRESENTATIONS
A KEYHOLE REVIEW OF THE LARGE PARADIGM SHIFT IN AORTIC SURGERY: A CASE STUDY OF THO-
RACIC ENDOVASCULAR AORTIC REPAIR (TEVAR) FOR DISTAL AORTIC ARCH PSEUDOANEURYSM IN A
ID 62 PATIENT WITH MULTIPLE SEVERE UNDERLYING MEDICAL CONDITIONS
MATTHEW WONG, PS LAW, SY SOON, YH JONG
Sarawak Heart Centre

MINIMALLY INVASIVE CORONARY ARTERY BYPASS GRAFTING SURGERY: A FOUR-YEAR EXPERIENCE

ID 63 NA MAZLAN, AY KHAMIS, AM HAMZAH
Hospital Pulau Pinang

51
 BOOTH LAYOUT

52
53
54
55
56
The organising committee of the 32nd MATCVS Annual Scientific Meeting and Biannual General
Meeting would like to express our appreciation to the following for their support and contribution:

PLATINUM SPONSOR

DIAMOND SPONSOR

GOLD SPONSOR

SILVER SPONSOR

57